Preliminary results on 225Ac-DOTATATE Targeted Alpha Therapy in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: First Clinical Experience on Safety and Efficacy

被引：0
|
作者：
Ballal, S. [1 ]
Yadav, M. P. [1 ]
Bal, C. [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-761
引用
收藏
页码：S288 / S288
页数：1
相关论文
共 50 条
  • [1] Early results of 225Ac-DOTATATE Targeted Alpha Therapy in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: First Clinical Experience on Safe and Efficacy
    Ballal, Sanjana
    Yadav, Madhav
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [2] Safety and Therapeutic Efficacy of 225Ac-DOTATATE Targeted Alpha Therapy in Metastatic Gastroenteropancreatic Neuroendocrine Tumors Stable or Refractory to 177Lu-DOTATATE PRRT
    Bal, Chandrasekhar
    Yadav, Madhav
    Ballal, Sanjana
    Tripathi, Madhavi
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [3] Efficacy of 225Ac-DOTATATE Targeted Alpha Therapy in Metastatic Gastroenteropancreatic Neuroendocrine Tumors Stable or Refractory to 177Lu-DOTATATE PRRT
    Ballal, S.
    Yadav, M.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S85 - S85
  • [4] Long-term outcome of 225Ac-DOTATATE Targeted Alpha Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors
    Bal, Chandrasekhar
    Ballal, Sanjana
    Yadav, Madhav
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [5] Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
    Ballal, Sanjana
    Yadav, Madhav Prasad
    Bal, Chandrasekhar
    Sahoo, Ranjit Kumar
    Tripathi, Madhavi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 934 - 946
  • [6] Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
    Sanjana Ballal
    Madhav Prasad Yadav
    Chandrasekhar Bal
    Ranjit Kumar Sahoo
    Madhavi Tripathi
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 934 - 946
  • [7] Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study
    Madhav Prasad Yadav
    Sanjana Ballal
    Ranjit Kumar Sahoo
    Chandrasekhar Bal
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1595 - 1606
  • [8] Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Sahoo, Ranjit Kumar
    Bal, Chandrasekhar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (05) : 1595 - 1606
  • [9] Efficacy and Safety of 225Ac-DOTATATE in the Treatment of Neuroendocrine Neoplasms With High SSTR Expression
    Yang, Hongyu
    Zhang, Yu
    Li, Hongmei
    Zhang, Yu
    Feng, Yue
    Yang, Xiqun
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 505 - 512
  • [10] Clinical Experience on 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients: Safety and Efficacy Results
    Bal, Chandrasekhar
    Yadav, Madhav
    Ballal, Sanjana
    Tripathi, Madhavi
    Sahoo, Ranjit
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345